Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSPO | P30536 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | RAD52 | P43351 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.34 |
| ▸ | KRAS | P01116 | 2/20 | 0.34 |
| ▸ | ACHE | P22303 | 2/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27119982 | 0.89 | TSPO (0.41) | TSPOMEN1RAD52KMT2AALDH1A1 | |
| SCHEMBL27890474 | 0.87 | TSPO (0.35) | TSPOMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL2556764 | 0.87 | SLC22A12 (0.38) | TSPOMEN1RAD52KMT2AALDH1A1 | |
| SCHEMBL2228899 | 0.87 | ALDH1A1 (0.34) | TSPOMEN1KMT2AALDH1A1DNM1 | |
| SCHEMBL11926705 | 0.87 | ALDH1A1 (0.47) | MEN1KMT2AALDH1A1MAPTLMNA | |
| SCHEMBL12166092 | 0.86 | KRAS (0.35) | TSPOMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL12166087 | 0.85 | ACHE (0.35) | TSPOMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL12166118 | 0.85 | TSPO (0.38) | TSPOMEN1RAD52KMT2AALDH1A1 | |
| SCHEMBL1894782 | 0.85 | TSPO (0.38) | TSPOMEN1RAD52KMT2AALDH1A1 | |
| SCHEMBL12166093 | 0.84 | DDB1 (0.33) | TSPOALDH1A1MAPTSLC22A12SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9708262-B2 | Compounds for electronic devices | MERCK PATENT GMBH (DE) | 2017-07-18 | — | — | US | disclosed |
| US-9708262-B2 | Compounds for electronic devices | MERCK PATENT GMBH (DE) | 2017-07-18 | — | — | US | disclosed |
| US-9708262-B2 | Compounds for electronic devices | MERCK PATENT GMBH (DE) | 2017-07-18 | — | — | US | disclosed |
| US-9422287-B2 | Bridged triarylamines and -phosphines as materials for electronic devices | MERCK PATENT GMBH (DE) | 2016-08-23 | — | — | US | disclosed |
| US-9422287-B2 | Bridged triarylamines and -phosphines as materials for electronic devices | MERCK PATENT GMBH (DE) | 2016-08-23 | — | — | US | disclosed |
| US-9422287-B2 | Bridged triarylamines and -phosphines as materials for electronic devices | MERCK PATENT GMBH (DE) | 2016-08-23 | — | — | US | disclosed |
| US-20150340613-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2015-11-26 | — | — | US | disclosed |
| US-20150340613-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2015-11-26 | — | — | US | disclosed |
| US-20150340613-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2015-11-26 | — | — | US | disclosed |
| US-9133119-B2 | Compounds for electronic devices | MERCK PATENT GMBH (DE) | 2015-09-15 | — | — | US | disclosed |
| US-20120292576-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2012-11-22 | — | — | US | disclosed |
| US-20120292576-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2012-11-22 | — | — | US | disclosed |
| CN-102725268-A | Compounds for electronic devices | MERCK PATENT GMBH | 2012-10-10 | — | — | CN | disclosed |
| US-20120232241-A1 | NITROGEN-CONTAINING CONDENSED HETEROCYCLIC COMPOUNDS FOR OLEDS | MERCK PATENT GMBH PATENTS & SCIENTIFIC INFORMATION (DE) | 2012-09-13 | — | — | US | disclosed |
| US-20120202997-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2012-08-09 | — | — | US | disclosed |
| CN-102612518-A | Nitrogen-containing condensed heterocyclic compounds for oleds | MERCK PATENT GMBH | 2012-07-25 | — | — | CN | disclosed |
| WO-2011128017-A1 | BRIDGED TRIARYLAMINES AND -PHOSPHINES AS MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2011-10-20 | — | — | WO | disclosed |
| WO-2011128017-A1 | BRIDGED TRIARYLAMINES AND -PHOSPHINES AS MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2011-10-20 | — | — | WO | disclosed |
| WO-2011088877-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2011-07-28 | — | — | WO | disclosed |
| WO-2011060867-A1 | NITROGEN-CONTAINING CONDENSED HETEROCYCLIC COMPOUNDS FOR OLEDS | MERCK PATENT GMBH (DE) | 2011-05-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120232241-A1 | NITROGEN-CONTAINING CONDENSED HETEROCYCLIC COMPOUNDS FOR OLEDS | OCIAD2, OCIAD1, ODC1 | TSPO 2385/4885MEN1 1948/4885RAD52 1704/4885 |
| US-20150340613-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | SLCO4C1, SLCO1A2, SLCO2A1 | TSPO 798/4885MEN1 575/4885RAD52 2231/4885 |
| US-20120202997-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | EPCAM, L1CAM, OR10J3 | TSPO 1784/4885MEN1 470/4885RAD52 1995/4885 |
| US-20120292576-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | SLCO4C1, SLCO1A2, SLCO2A1 | TSPO 798/4885MEN1 575/4885RAD52 2231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.